Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum

被引:6
作者
Szczesna-Skorupa, Elzbieta [1 ]
Kemper, Byron [1 ]
机构
[1] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA
基金
美国国家卫生研究院;
关键词
Cytochrome P450; MG132; Endoplasmic reticulum; Intracellular trafficking; Proteasome; BAP31; sec61; Calnexin; ER-associated degradation (ERAD);
D O I
10.1016/j.yexcr.2008.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine whether protein degradation plays a role in the endoplasmic reticulum (B) retention of cytochromes P450, the effects of proteasomal inhibitors oil the expression and distribution of green fluorescent protein chimeras of CYP2C2 and related proteins was examined. in transfected cells, expression levels of chimeras of full-length CYP2C2 and its cytosolic domain, but not its N-terminal transmembrane sequence, were increased by proteasomal inhibition. Redistribution of all three chimeras from the reticular ER into a perinuclear compartment and, in a subset of cells, also to the cell surface was observed after proteasomal inhibition. Redistribution was blocked by the microtubular inhibitor, nocodazole, Suggesting that redistribution to the cell surface followed the conventional vesicular transport pathway. Similar redistributions were detected for BAP31, a CYP2C2 binding chaperone; CYP2E1 and CYP3A4, which are also degraded by the proteasomal pathway; and for cytochrome P450 reductase, which does not undergo proteasomal degradation; but not for the ER membrane proteins, sec61 and calnexin. Redistribution does not result from saturation of an ER retention "receptor" since in some cases protein levels Were unaffected. Proteasomal inhibition may, therefore, alter ER retention by affecting a protein critical for ER retention, either directly, or indirectly by affecting the composition of the ER membranes. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:3221 / 3231
页数:11
相关论文
共 63 条
[11]  
Eliasson E, 1996, MOL PHARMACOL, V50, P573
[12]   Quality control in the yeast secretory pathway -: A misfolded Pma1 H+-ATPase reveals two checkpoints [J].
Ferreira, T ;
Mason, AB ;
Pypaert, M ;
Allen, KE ;
Slayman, CW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :21027-21040
[13]   After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes [J].
Franz, S. ;
Herrmann, K. ;
Fuehrnrohr, B. ;
Sheriff, A. ;
Frey, B. ;
Gaipl, U. S. ;
Voll, R. E. ;
Kalden, J. R. ;
Jaeck, H. -M. ;
Herrmann, M. .
CELL DEATH AND DIFFERENTIATION, 2007, 14 (04) :733-742
[14]   Evidence for recycling of cytochrome P450 sterol 14-demethylase from the cis-Golgi compartment to the endoplasmic reticulum (ER) upon saturation of the ER-retention mechanism [J].
Homma, K ;
Yoshida, Y ;
Nakano, A .
JOURNAL OF BIOCHEMISTRY, 2000, 127 (05) :747-754
[15]  
Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5
[16]   Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells [J].
Huan, JY ;
Streicher, JM ;
Bleyle, LA ;
Koop, DR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 199 (03) :332-343
[17]   A striking quality control subcompartment in Saccharomyces cerevisiae:: The endoplasmic reticulum-associated compartment [J].
Huyer, G ;
Longsworth, GL ;
Mason, DL ;
Mallampalli, MP ;
McCaffery, JM ;
Wright, RL ;
Michaelis, S .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (02) :908-921
[18]   Aggresomes: A cellular response to misfolded proteins [J].
Johnston, JA ;
Ward, CL ;
Kopito, RR .
JOURNAL OF CELL BIOLOGY, 1998, 143 (07) :1883-1898
[19]   A novel quality control compartment derived from the endoplasmic reticulum [J].
Kamhi-Nesher, S ;
Shenkman, M ;
Tolchinsky, S ;
Fromm, SV ;
Ehrlich, R ;
Lederkremer, GZ .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (06) :1711-1723
[20]   Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones [J].
Kim, PS ;
Arvan, P .
ENDOCRINE REVIEWS, 1998, 19 (02) :173-202